Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Core Insights - Evogene Ltd. will present its pharmaceutical discovery achievements at the BIO-Europe Spring 2026 conference in Lisbon, Portugal, from March 23-25, 2026 [1] - The presentation will focus on technological breakthroughs in AI-driven small-molecule discovery and optimization, particularly through the use of ChemPass AI™ [1] Company Overview - Evogene Ltd. specializes in computational chemistry and the generative design of small molecules for pharmaceutical and agricultural industries [1] - The company's technology, ChemPass AI™, is designed to explore vast chemical spaces and generate novel, highly potent small molecules optimized across multiple critical parameters [1] - Evogene aims to create breakthrough products by integrating scientific innovation with real-world industry needs through strategic partnerships and internal product development [1] Conference Details - Dr. Gabi Tarcic and Dr. Olga Nissan will represent Evogene at the conference, with Dr. Nissan delivering an oral presentation on March 24, 2026 [1] - One-on-one meetings will be available for interested parties to discuss potential collaborations [1]